✦ LIBER ✦

Estimation of D2-like dopamine receptor occupancy by dopamine in the MPTP primate model of Parkinson's disease

✍ Scribed by Svetlana Chefer; A Kimes; E Domino; E London; A Mukhin

Book ID: 118490050
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 56 KB
Volume: 31
Category: Article
ISSN: 1053-8119
DOI: 10.1016/j.neuroimage.2006.04.127

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2.217 PHARMACOKINETIC PROFILE OF THE SEL

2.217 PHARMACOKINETIC PROFILE OF THE SELECTIVE DOPAMINE D4 RECEPTOR ANTAGONIST L-745,870 IN THE MPTP-LESIONED NON-HUMAN PRIMATE MODEL OF PARKINSON'S DISEASE

✍ P. Huot; J.B. Koprich; T.H. Johnston; S.H. Fox; J.M. Brotchie 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Sigma1 and dopamine D2 receptor occupanc

Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands

✍ Kiichi Ishiwata; Kazunori Kawamura; Tadayuki Kobayashi; Kiyoshi Matsuno 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Pinhole SPECT imaging of dopamine transp

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

✍ Gerda Andringa; Benjamin Drukarch; John G.J.M. Bol; Kora de Bruin; Karolina Sorm 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Antiparkinsonian effects of the novel D3

Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors

✍ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept

[Methods in Molecular Biology] Dopamine

[Methods in Molecular Biology] Dopamine Volume 964 || The MPTP/Probenecid Model of Progressive Parkinson’s Disease

✍ Kabbani, Nadine 📂 Article 📅 2012 🏛 Humana Press ⚖ 522 KB

Pharmacological characterization of psyc

Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease

✍ Naomi P. Visanji; Jordi Gomez-Ramirez; Tom H. Johnston; Donna Pires; Valerie Voo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

## Abstract Investigation of the pathophysiology of psychosis in Parkinson's disease (PD), as well as the assessment of potential novel therapeutics, has been limited by the lack of a well‐validated animal model. MPTP‐lesioned primates exhibit abnormal behaviors that are distinct from dyskinesia an